Yeast sensors for novel drugs: chloroquine and others revealed

Sensors (Basel). 2012 Sep 26;12(10):13058-74. doi: 10.3390/s121013058.

Abstract

In this study the mitochondrion is regarded as a target to reveal compounds that may be used to combat various diseases. Consequently, the sexual structures of yeasts (with high mitochondrial activity) were identified as sensors to screen for various anti-mitochondrial drugs that may be toxic to humans and that are directed, amongst others, against fungal diseases and cancer. Strikingly, these sensors indicated that chloroquine is a potent pro-mitochondrial drug which stimulated yeast sexual reproduction. In addition, these sensors also showed that some Non-Steroidal Anti-Inflammatory drugs (NSAIDs), anti-malarial drugs, antifungal and anticancer drugs are anti-mitochondrial. These yeast sensor bio-assays may fast track studies aimed at discovering new drugs as well as their mechanisms and should now be further evaluated for selectivity towards anti-/ pro-mitochondrials, fertility drugs and contraceptives, using in vitro, in vivo, in silico and omics research.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / isolation & purification
  • Antineoplastic Agents / isolation & purification
  • Biological Assay / methods*
  • Biosensing Techniques / methods*
  • Chloroquine / isolation & purification*
  • Drug Discovery / methods*
  • Eremothecium / physiology
  • Humans
  • Lipomyces / physiology
  • Mitochondria / drug effects
  • Yeasts / physiology*

Substances

  • Antifungal Agents
  • Antineoplastic Agents
  • Chloroquine